The race to develop the next generation of weight loss drugs has taken an interesting new turn. In recent research, Eli Lilly ...

Panelists discuss how SC delivery enhances patient convenience and health care efficiency in NSCLC treatment.

The weight loss drug company was counted out far too early in the summer, but investors are warming to it again.

Results of CheckMate 67T, a phase 3 noninferiority study comparing subcutaneous and intravenous nivolumab formulations in RCC, were presented at JADPRO 2025.

NEW ORLEANS -- Patients experiencing major heart attacks had a lower risk of serious complications if they received a single ...

Panelists discuss how recent FDA approvals and SC amivantamab data support broader use of subcutaneous therapy in NSCLC.

Subcutaneous immunotherapy injections work the same way as their intravenous counterparts — by changing or enhancing a person’s immune responses to cancer. Immunotherapy for cancer is a broad category ...

New York, March 10, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Subcutaneous Biologics, Technologies and Drug Delivery Systems Market by Type of Biologic, Type of ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Patients with rheumatoid arthritis in low ...

Down-titrating vial concentrations when restarting subcutaneous allergen immunotherapy after treatment gaps may help lower ...

Implantable cardioverter–defibrillators (ICDs) prevent sudden death from cardiac causes in selected patients but require the use of transvenous lead systems. To eliminate the need for venous access, ...